Latest Lymphoma News Articles | DLBCL Information

Lymphoma News

LYMPHOMA ADVISOR

Lymphoma News

Biosimilar Riabni Gets FDA Approval

The biosimilar has been approved for the treatment of Non-Hodgkin’s Lymphoma, Chronic Lymphocytic Leukemia, Granulomatosis with Polyangiitis, and Microscopic Polyangiitis.
Next post in Lymphoma